Teqmed Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Raipur, Chattisgarh, India, established in 2021.
2021 Raipur, Chattisgarh, India Active
Last Updated:
Access Report
About Teqmed Pharma Llp

Teqmed Pharma Llp, a active limited liability partnership, was established on 23 October 2021 in Raipur, Chattisgarh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds LLPIN: AAZ-1599. Registered under ROC Roc Chhattisgarh. It has total obligation of contribution of ₹0.15 M.

Its leadership includes Dinesh Kumar Sen (Designated Partner), Roshni Sharma (Designated Partner). Past directors included Rinku Kapil. It holds ₹3.50 M open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2024. It is based at Near Disha College, Kota Road,, Raipur, Chattisgarh, 492001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAZ-1599

  • Incorporation Date

    23 October 2021

  • Total Obligation of Contribution

    ₹0.15 M

  • ROC Code

    Roc Chhattisgarh

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.15 M
  • Company Age 4 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.50 M
Company report

Teqmed Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Teqmed Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Teqmed Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Dinesh Kumar Sen Designated Partner 23 Oct 2021 Current
Roshni Sharma Designated Partner 23 Oct 2021 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Teqmed Pharma Llp.

Enhance accessibility to Teqmed Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Teqmed Pharma Llp revenue growth over time
Teqmed Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Teqmed Pharma Llp?

Unlock access to Teqmed Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 0.35 Cr
Latest Charge Details
Date Lender Amount Status
25 Apr 2024 State Bank Of India ₹3.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Teqmed Pharma Llp?

Unlock and access historical data on people associated with Teqmed Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Teqmed Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Teqmed Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Teqmed Pharma Llp
Recent Activity within the Organization
  • Charges

    A charge with State Bank Of India amounted to Rs. 3.50 M with Charge ID 100921376 was registered on 25 Apr 2024. was recorded as a recent event.

  • Annual General Meeting

    Teqmed Pharma Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Teqmed Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chhattisgarh. was documented.

  • Director Appointment

    Progress on Dinesh Kumar Sen was appointed as a Designated Partner was appointed as a Designated Partner on 23 Oct 2021 & has been associated with this company since 4 years 3 months . was documented.

  • Director Appointment

    The activity Roshni Sharma was appointed as a Designated Partner was appointed as a Designated Partner on 23 Oct 2021 & has been associated with this company since 4 years 3 months . was completed.

  • LLP Incorporation

    The activity Teqmed Pharma Llp was registered on 23 Oct 2021 with Roc Chhattisgarh & aged 4 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Teqmed Pharma Llp?

The LLPIN of Teqmed Pharma Llp is AAZ-1599.

Where is Teqmed Pharma Llp headquartered?

Teqmed Pharma Llp is headquartered at Near Disha College, Kota Road,, Raipur, Chattisgarh, 492001.

When was Teqmed Pharma Llp incorporated?

Teqmed Pharma Llp was incorporated on 23 October 2021.

Who are the current directors of Teqmed Pharma Llp?

The current directors of Teqmed Pharma Llp are

What is the primary industry of Teqmed Pharma Llp?

The primary industry of Teqmed Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available